fbpx
October 28, 2022

Lower PSA Screening Rates Linked to Rise in Mets Prostate Cancer Lower PSA Screening Rates Linked to Rise in Mets Prostate Cancer

SAN ANTONIO — Veterans Administration (VA) medical centers with lower prostate-specific antigen (PSA) screening rates reported higher rates of metastatic prostate cancer, a recent retrospective analysis […]
October 28, 2022

Combining Treatments for Scar Revision Often a Useful Approach Combining Treatments for Scar Revision Often a Useful Approach

When Arisa E. Ortiz, MD, meets with patients who seek treatment options for scars, the first thing she explains is that she can’t erase them. Dr Arisa […]
October 28, 2022

Intensive BP Lowering Harmful in Acute Ischemic Stroke Intensive BP Lowering Harmful in Acute Ischemic Stroke

A large randomized trial that was investigating intensive lowering of blood pressure in acute ischemic stroke patients who had undergone mechanical thrombectomy has been stopped early […]
October 28, 2022

Secondary RAS Mutations Linked to Thyroid Cancer Severity, Mortality Secondary RAS Mutations Linked to Thyroid Cancer Severity, Mortality

Dr Athanasios Bikas MONTREAL — Key genetic mutations secondary to RAS mutations that are common in differentiated thyroid cancer (DTC) strongly correlate with higher risk and more […]
October 28, 2022

First-in-Class Device for Facial Wrinkles Hits the Market First-in-Class Device for Facial Wrinkles Hits the Market

DENVER – One expert’s clinical experience suggests that Ellacor, a dermal microcoring device that became available in the United States in October 2022, is an effective […]
October 28, 2022

Radiotherapy Plus Hormone Therapy Boosts Prostate Cancer Outcomes Radiotherapy Plus Hormone Therapy Boosts Prostate Cancer Outcomes

SAN ANTONIO — Adding metastasis-directed therapy (MDT) to intermittent hormone therapy significantly improved progression-free survival (PFS) in patients with oligometastatic prostate cancer, allowing patients relief from […]
October 28, 2022

Fertility Physicians Say They Lack Access to Miscarriage Drugs Fertility Physicians Say They Lack Access to Miscarriage Drugs

In a survey taken before the Supreme Court’s Dobbs ruling regarding abortion rights, two-thirds of assisted reproduction technology (ART) physicians who don’t offer mifepristone/misoprostol to patients […]
October 28, 2022

Legal and Malpractice Risks When Taking Call Legal and Malpractice Risks When Taking Call

Taking call is one of the more challenging ― and annoying ― aspects of the job for many physicians. Calls may wake them up in the […]
October 28, 2022

NIH to Test Pfizer’s Paxlovid for Long COVID NIH to Test Pfizer’s Paxlovid for Long COVID

CHICAGO (Reuters) – The U.S. National Institutes of Health’s $1 billion RECOVER Initiative has picked Pfizer Inc’s antiviral drug Paxlovid as the first treatment it will […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556557558559560561562563564565566567568569570571572573574575576577578579580581582583584585586587588589590591592593594595596597598599600601602603604605606607608609610611612613614615616617618619620621622623624625626627628629630631632633634635636637638639640641642643644645646647648649650651652653654655656657658659660661662663664665666667668669670671672673674675676677678679680681682683684685686687688689690691692693694695696697698699700701702703704705706707708709710711712713714715716717718719720721722723724725726727728729730731732733734735736737738739740741742743744745746747748749750751752753754755756757758759760761762763764765766767768769770771772773774775776777778779780781782783784785786787788789790791792793794795796797798799800801802803804
Next page
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0